Featuring: Priya Kumthekar, MD
An early clinical trial found that a spherical nucleic acid drug developed at Northwestern kills tumor cells in people with the fatal brain cancer glioblastoma. This is the first time a nanotherapeutic has been shown to cross the blood-brain barrier and cause cell death. Lead investigator Priya Kumthekar, MD, explains the results of the study.
Physicians who listen to this podcast may claim continuing medical education credit after listening to an episode of this program.
This podcast was originally release via the Feinberg School of Medicine News Center in March 2021.
Priya Kumthekar, MD
Northwestern Medicine welcomes the opportunity to partner with you in caring for your patients.